Human β defensins-1, an antimicrobial peptide, kills Candida glabrata by generating oxidative stress and arresting the cell cycle in G0/G1 phase
Open Access
- 18 August 2022
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 154, 113569
Abstract
No abstract availableKeywords
Funding Information
- Deanship of Scientific Research, Prince Sattam bin Abdulaziz University
- King Abdulaziz University
- Ministry of Education - Kingdom of Saudi Arabia (IFPRC-085-130-2020)
This publication has 37 references indexed in Scilit:
- Global trends in the distribution of Candida species causing candidemiaClinical Microbiology and Infection, 2014
- Two unlike cousins:
C
andida albicans
and
C
. glabrata
infection strategiesCellular Microbiology, 2013
- The changing epidemiology of healthcare-associated candidemia over three decadesDiagnostic Microbiology and Infectious Disease, 2012
- Candida glabrata, Candida parapsilosisandCandida tropicalis: biology, epidemiology, pathogenicity and antifungal resistanceFEMS Microbiology Reviews, 2012
- Effect of diallyldisulphide on an antioxidant enzyme system inCandidaspeciesCanadian Journal of Microbiology, 2010
- Structures of Human Host Defense Cathelicidin LL-37 and Its Smallest Antimicrobial Peptide KR-12 in Lipid MicellesJournal of Biological Chemistry, 2008
- Human β-Defensins Kill Candida albicans in an Energy-Dependent and Salt-Sensitive Manner without Causing Membrane DisruptionAntimicrobial Agents and Chemotherapy, 2007
- Human β-Defensins 2 and 3 Demonstrate Strain-Selective Activity against Oral MicroorganismsJournal of Clinical Microbiology, 2004
- Antimicrobial Characterization of Human β-Defensin 3 DerivativesAntimicrobial Agents and Chemotherapy, 2003
- Isolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide AntibioticJournal of Biological Chemistry, 2001